Sei Ryang Oh
37Patents
1h-index
111Co-inventors
56Inventor score
Filing activity: May 30, 2006 → Aug 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9895337B2 | Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis | Human Necessities | 2 | Active |
| US10058527B2 | Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis | Human Necessities | 1 | Active |
| US8168235B2 | Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity | Human Necessities | 0 | Active |
| US9481630B2 | Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same | Chemistry; Metallurgy | 0 | Active |
| US9428520B2 | Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis | Human Necessities | 0 | Active |
| US9999646B2 | Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient | Human Necessities | 0 | Active |
| US10046019B2 | Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma | Human Necessities | 0 | Active |
| US8980846B2 | Composition containing styraxlignolide A or the aglycone thereof as an active ingredient for preventing or treating asthma | Human Necessities | 0 | Active |
| US8299049B2 | Compositions comprising an extract of Tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases | Human Necessities | 0 | Active |
| US8883226B2 | Pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma containing an extract of Decaspermum fruticosum | Human Necessities | 0 | Active |
| US7763286B2 | Composition comprising an extract of Tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity | Human Necessities | 0 | Active |
| US9061022B2 | Pharmaceutical composition for treating wounds or revitalizing skin comprising Euphorbia kansui extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient | Human Necessities | 0 | Active |
| US10172816B2 | Method of treating chronic obstructive pulmonary disease (CPD) with verproside | Human Necessities | 0 | Active |
| US8974837B2 | Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity | Human Necessities | 0 | Active |
| US9174925B2 | Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same | Chemistry; Metallurgy | 0 | Active |
| US9610310B2 | Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient | Human Necessities | 0 | Active |
| US10751378B2 | Pharmaceutical composition comprising Pistacia weinmannifolia extract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD) | Human Necessities | 0 | Active |
| US8455541B2 | Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity | Human Necessities | 0 | Active |
| US9592263B2 | Purified extract (ATC2) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma | Human Necessities | 0 | Active |
| US11135193B2 | Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma | Human Necessities | 0 | Active |
| US10406187B2 | Method for treating neuroinflammation with a pharmaceutical composition containing Portulaca grandiflora hook. extract or fraction thereof as active ingredient | Human Necessities | 0 | Active |
| US9763908B2 | Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis | Human Necessities | 0 | Active |
| US10413579B2 | Pharmaceutical composition for preventing or treating asthma comprising Pistacia weinmannifolia J. Poiss. ex Franch extract or fraction thereof | Human Necessities | 0 | Active |
| US12390505B2 | Composition for preventing or treating obesity or diabetes, comprising acanthopanax senticosus extract and garcinia cambogia extract or compound isolated therefrom | Human Necessities | 0 | Active |
| US10053443B2 | 2-phenylbenzofuran derivatives, method for preparing the same and use of the same for treating inflammatory disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.